Novartis: Hepatitis B trials
The registry lists 11 Hepatitis B studies with Novartis as lead sponsor. 0 are open to participants now and 5 have results posted.
Phase 1 1Phase 2 3Phase 3 6Phase 4 1No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate VaccineCompletedNCT01453348Phase 3Results posted
- Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHBCompletedNCT00805675Phase 3Results posted
- Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB)TerminatedNCT00412750Phase 3Results posted
- Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis BCompletedNCT00412529Phase 3Results posted
- Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir AloneTerminatedNCT00376259Phase 3Results posted
- Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of AgeCompletedNCT01470287Phase 3
- Epidemiological Study in Children and Adolescents With Chronic Hepatitis BCompletedNCT01163240
- Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection SubjectsTerminatedNCT00964665Phase 1/2
- To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)CompletedNCT00537537Phase 4
- Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis BCompletedNCT00128544Phase 2
- An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis BCompletedNCT00124241Phase 2